Tandem and Eli Lilly carried out trials to demonstrate the advantages of using Lyumjev in combination with Control-IQ ...

Tandem Diabetes Care (Nasdaq:TNDM) announced today that it received clearance for the use of rapid-acting insulin with its ...

Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, today announced that ...

Tandem Diabetes Care (NASDAQ: TNDM) had some encouraging news to report on the regulatory front Thursday, and after it hit ...

The unintended side effect of using the app is the rapid depletion of Tandem’s t:slim insulin pump batteries. This may be caused by the app retrieving more data than intended, causing excessive ...

Two hospitalizations and no deaths have been reported. Recommendations for Impacted t:slim X2 Pump Users Tandem strongly recommends anyone using the Apple iOS t:connect Mobile App with a t ...

Its products include Tandem Mobi System and t:slim X2 Insulin Pump. The company was founded by Paul M. DiPerna on January 27, 2006, and is headquartered in San Diego, CA.

First announced in China last month, but now getting a global launch - excepting the US, of course - the new MatePad Pro is ...

Tandem encourages all impacted t:slim X2 iOS users to update their mobile app as soon as the new version is available in the Apple App Store. Under-delivery of insulin because of a pump shutdown can ...

Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, today announced that its t:slim X2 insulin pump with Control-IQ automated insulin delivery (AID) ...